Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by investclubon Sep 10, 2019 12:15pm

100 Views

Post# 30112849

RE:RE:1st patient of PH2

You might be surprised winr88 early results should have a big impact on share price with expectations that PH2 results will replicate patients 5 & 6 from PH1. Each patient being treated and with hope TLT releases results on each for periods of 7, 30, 60 90 etc. as said should they show 100% CR (complete response) if share price doesn't go up impressively then I would speculate our sun will remain motionless in the sky.

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario